Incisive coverage of the issues important to vaping. Plus critical debate over the issues and impacts of regulation in both Canada and the U.S.
Episodes
Aug 19, 2024
Aug 19, 2024
39 min
Industry funding taints all science, research, and tobacco harm reduction advocacy, no matter how stringent the firewalls or how far the funding is removed. This criticism is a convenient argument for detractors of safer nicotine products to deny the truth about nicotine and relative risk.
Joining us today to unpack the dangers and consequences of dismissing the truth about tobacco harm reduction is Clifford E. Douglas, President and CEO of Global Action to End Smoking.
Has public understanding about safer nicotine products been shortchanged?
Find out! Only on RegWatch by RegulatorWatch.com.
Released: August 19, 2024
Produced by Brent Stafford
Make RegWatch happen, go to https://support.regulatorwatch.com
#RegWatch #VapeNews
No comments yet. Be the first to say something!